Prelude Therapeutics Cash Flow Statement 2019-2024 | PRLD

Fifteen years of historical annual cash flow statements for Prelude Therapeutics (PRLD).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
20232022202120202019
$-121.83$-115.44$-111.69$-56.93$-27.57
$-2.30$3.92$2.28$0.54$0.38
$27.55$26.86$22.26$5.59$0.86
$25.25$30.78$24.54$6.14$1.24
$0$0$0$0$0
$0$0$0$0$0
$-2.27$-0.35$3.90$1.16$0.55
$-10.73$-5.55$-2.74$-1.16$-1.35
$-10.48$0.93$3.63$4.62$0.67
$-107.06$-83.73$-83.53$-46.18$-25.67
$-3.51$-3.02$-2.32$-0.62$-0.78
$0$0$0$0$0
$0$0$0$0$0
$-31.13$84.71$-261.48$0$0
$0$0$0$0$0
$-31.13$84.71$-261.48$0$0
$0$0$0$0$0
$-34.65$81.69$-263.80$-0.62$-0.78
$0$0$0$-0.26$-0.12
$0$0$0$0$0
$0$0$0$-0.26$-0.12
$136$0.82$165$167$0.01
$136$0.82$165$246$29.85
$0$0$0$0$0
$-0.02$0$-0.30$-0.01$0
$136$0.82$165$246$29.73
$-5.31$-1.22$-182.44$199$3.28
$25.62$25.14$20.93$5.58$0.85
$0$0$0$0$0